JP2022543859A5 - - Google Patents
Info
- Publication number
- JP2022543859A5 JP2022543859A5 JP2022507792A JP2022507792A JP2022543859A5 JP 2022543859 A5 JP2022543859 A5 JP 2022543859A5 JP 2022507792 A JP2022507792 A JP 2022507792A JP 2022507792 A JP2022507792 A JP 2022507792A JP 2022543859 A5 JP2022543859 A5 JP 2022543859A5
- Authority
- JP
- Japan
- Prior art keywords
- pyran
- tetrahydro
- triazole
- thio
- hydroxymethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2019071399 | 2019-08-09 | ||
| EPPCT/EP2019/071399 | 2019-08-09 | ||
| PCT/EP2020/072197 WO2021028323A1 (en) | 2019-08-09 | 2020-08-06 | (2-acetamidyl)thio-beta-d-galactopyranoside derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022543859A JP2022543859A (ja) | 2022-10-14 |
| JP2022543859A5 true JP2022543859A5 (enExample) | 2023-08-14 |
| JP7612663B2 JP7612663B2 (ja) | 2025-01-14 |
Family
ID=71944145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022507792A Active JP7612663B2 (ja) | 2019-08-09 | 2020-08-06 | （２－アセタミジル）チオ－ベータ－ｄ－ガラクトピラノシド誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12410208B2 (enExample) |
| EP (1) | EP4010348B1 (enExample) |
| JP (1) | JP7612663B2 (enExample) |
| KR (1) | KR102863667B1 (enExample) |
| CN (1) | CN114206892A (enExample) |
| CA (1) | CA3147078A1 (enExample) |
| ES (1) | ES2974680T3 (enExample) |
| TW (1) | TWI860392B (enExample) |
| WO (1) | WO2021028323A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114206893A (zh) | 2019-08-09 | 2022-03-18 | 爱杜西亚药品有限公司 | (杂)芳基-甲基-硫代-β-D-吡喃半乳糖苷衍生物 |
| MA56883B1 (fr) | 2019-08-15 | 2025-04-30 | Idorsia Pharmaceuticals Ltd | Dérivés de 2-hydroxycycloalcane-1-carbamoyle |
| CN114585619B (zh) | 2019-08-29 | 2024-09-27 | 爱杜西亚药品有限公司 | α-D-吡喃半乳糖苷衍生物 |
| US12312362B2 (en) | 2020-10-06 | 2025-05-27 | Idorsia Pharmaceuticals Ltd | Spiro derivatives of Alpha-D-galactopyranosides |
| EP4237419A1 (en) | 2020-11-02 | 2023-09-06 | Idorsia Pharmaceuticals Ltd | Galectin-3 inhibiting 2-hydroxycycloalkane-1 -carbamoyl derivatives |
| CN116806219A (zh) | 2021-02-09 | 2023-09-26 | 爱杜西亚药品有限公司 | 羟基杂环烷-氨甲酰基衍生物 |
| RS67032B1 (sr) | 2021-03-03 | 2025-08-29 | Idorsia Pharmaceuticals Ltd | Alfa-d-galaktopiranozidni derivati supstituisani triazolil-metilom |
| WO2022189459A2 (en) * | 2021-03-10 | 2022-09-15 | Galecto Biotech Ab | Novel galactoside inhibitor of galectins |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0100172D0 (sv) | 2001-01-22 | 2001-01-22 | Ulf Nilsson | New inhibitors against galectins |
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| SE0401301D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| EP2620443A1 (en) | 2012-01-25 | 2013-07-31 | Galecto Biotech AB | Novel galactoside inhibitors of galectins |
| DK2906227T3 (en) | 2012-10-10 | 2018-12-10 | Galectin Therapeutics Inc | GALACTOSE-CONTAINING CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF DIABETIC Nephropathy |
| CN104755088A (zh) | 2012-10-31 | 2015-07-01 | 格莱克特生物技术公司 | 半乳凝集素-3的半乳糖苷抑制剂及其用于治疗肺纤维化的应用 |
| EP2919802A4 (en) | 2012-11-15 | 2016-09-14 | Univ Tufts | METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER |
| CA2970062C (en) | 2015-01-30 | 2023-02-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| PL3456717T3 (pl) | 2015-07-06 | 2021-10-25 | Gilead Sciences, Inc. | Pochodna 4,6-diaminochinolino-3-karbonitrylu jako modulator cot (cancer osaka thyroid) do leczenia choroby zapalnej |
| RU2724345C2 (ru) * | 2015-10-09 | 2020-06-23 | Галапагос Нв | N-СУЛЬФОНИЛИРОВАННЫЕ ПИРАЗОЛО[3,4-b]ПИРИДИН-6-КАРБОКСАМИДЫ И СПОСОБ ИХ ПРИМЕНЕНИЯ |
| CA3025867A1 (en) | 2016-07-12 | 2018-01-18 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| KR20200015528A (ko) | 2017-05-12 | 2020-02-12 | 갈랙틴 사이언시즈, 엘엘씨 | 전신 인슐린 내성 질환의 치료용 화합물 및 그의 용도 |
| EP3621973A4 (en) | 2017-05-12 | 2021-10-27 | Galectin Sciences, LLC | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND USES THEREOF |
| WO2019067702A1 (en) | 2017-09-27 | 2019-04-04 | Bristol-Myers Squibb Company | INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3 |
| US11072626B2 (en) | 2017-10-11 | 2021-07-27 | Bristol-Myers Squibb Company | Small molecule inhibitors of Galectin-3 |
| CA3080128A1 (en) | 2017-10-31 | 2019-05-09 | Galectin Sciences, Llc | Selenogalactoside compounds for the treatment of systemic insulin resistance disorders and the use thereof |
| CN113286632A (zh) | 2018-10-15 | 2021-08-20 | 格莱克特生物技术公司 | 半乳糖凝集素的半乳糖苷抑制剂前药 |
| JP2022508720A (ja) | 2018-10-15 | 2022-01-19 | ガレクト バイオテック エービー | ガレクチンのガラクトシド阻害剤 |
| WO2020104335A1 (en) | 2018-11-21 | 2020-05-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| US12269819B2 (en) | 2019-04-10 | 2025-04-08 | Bristol-Myers Squibb Company | Small molecule inhibitors of Galectin-3 |
| JP7674276B2 (ja) | 2019-07-03 | 2025-05-09 | ガレクト バイオテック エービー | ガレクチンの新規なガラクトシド阻害剤 |
| WO2021004940A1 (en) | 2019-07-05 | 2021-01-14 | Galecto Biotech Ab | Novel galactoside inhibitor of galectins |
| CN114206893A (zh) | 2019-08-09 | 2022-03-18 | 爱杜西亚药品有限公司 | (杂)芳基-甲基-硫代-β-D-吡喃半乳糖苷衍生物 |
| MA56883B1 (fr) | 2019-08-15 | 2025-04-30 | Idorsia Pharmaceuticals Ltd | Dérivés de 2-hydroxycycloalcane-1-carbamoyle |
| CN114585619B (zh) | 2019-08-29 | 2024-09-27 | 爱杜西亚药品有限公司 | α-D-吡喃半乳糖苷衍生物 |
| US12312362B2 (en) | 2020-10-06 | 2025-05-27 | Idorsia Pharmaceuticals Ltd | Spiro derivatives of Alpha-D-galactopyranosides |
| EP4237419A1 (en) | 2020-11-02 | 2023-09-06 | Idorsia Pharmaceuticals Ltd | Galectin-3 inhibiting 2-hydroxycycloalkane-1 -carbamoyl derivatives |
| CN116806219A (zh) | 2021-02-09 | 2023-09-26 | 爱杜西亚药品有限公司 | 羟基杂环烷-氨甲酰基衍生物 |
| RS67032B1 (sr) | 2021-03-03 | 2025-08-29 | Idorsia Pharmaceuticals Ltd | Alfa-d-galaktopiranozidni derivati supstituisani triazolil-metilom |
-
2020
- 2020-08-06 WO PCT/EP2020/072197 patent/WO2021028323A1/en not_active Ceased
- 2020-08-06 CA CA3147078A patent/CA3147078A1/en active Pending
- 2020-08-06 EP EP20750677.5A patent/EP4010348B1/en active Active
- 2020-08-06 ES ES20750677T patent/ES2974680T3/es active Active
- 2020-08-06 CN CN202080056498.7A patent/CN114206892A/zh active Pending
- 2020-08-06 US US17/633,941 patent/US12410208B2/en active Active
- 2020-08-06 KR KR1020227007694A patent/KR102863667B1/ko active Active
- 2020-08-06 JP JP2022507792A patent/JP7612663B2/ja active Active
- 2020-08-07 TW TW109126970A patent/TWI860392B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543859A5 (enExample) | ||
| JP2022543666A5 (enExample) | ||
| JP2023514872A5 (enExample) | ||
| US8962608B2 (en) | Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors | |
| CN106029064B (zh) | 治疗化合物和组合物 | |
| JP2022544248A5 (enExample) | ||
| JP6013734B2 (ja) | キノロン化合物の製造方法 | |
| JP2024506182A5 (enExample) | ||
| JP2022552655A5 (enExample) | ||
| EA032609B1 (ru) | Соединения аминопиримидинила в качестве ингибиторов jak | |
| JP2024509421A5 (enExample) | ||
| JP2005533827A5 (enExample) | ||
| CN105008367A (zh) | 作为钾离子通道抑制剂的吡咯并三嗪类化合物 | |
| RU2010110640A (ru) | Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ | |
| JP2018522047A (ja) | Ｒｏｒガンマモジュレータとしての新規化合物 | |
| JP7195436B2 (ja) | バニン阻害剤としての複素芳香族化合物 | |
| US10464896B2 (en) | Efflux-pump inhibitors and therapeutic uses thereof | |
| JP2022546029A5 (enExample) | ||
| CN111094255A (zh) | 具有环状结构的化合物 | |
| CN110191709A (zh) | 可用作吲哚胺2,3-双加氧酶和/或色氨酸双加氧酶抑制剂的化合物 | |
| EA018995B1 (ru) | Производные карбаматов алкилтиазолов, их получение и их применение в терапии | |
| CA2545092A1 (en) | Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity | |
| JP2023547241A5 (enExample) | ||
| JP2007521312A5 (enExample) | ||
| JP2007521313A5 (enExample) |